Free live webinar exploring the evolving role of imaging in the diagnosis, characterization, and management of NF1-associated plexiform neurofibromas, with multidisciplinary perspectives and updates on targeted therapies.
LEARNING OBJECTIVES
- Understanding Neurofibromatosis Type 1 (NF1): Definition and Epidemiology — define NF1 and describe its genetic basis and clinical spectrum; review global and regional epidemiology including prevalence and variability; recognize the burden of NF1 on patient quality of life and healthcare systems.
- Imaging in NF1: Optimizing Detection and Characterization of Plexiform Neurofibromas — identify the role of MRI in detection and characterization of plexiform neurofibromas (PN); apply radiologic criteria for PN assessment including differentiation from other soft-tissue lesions; interpret practical imaging case examples illustrating best practices in diagnosis and monitoring.
- Radiology–Clinic Collaboration: Case-Based Discussion on NF1-PN Diagnosis and Monitoring — demonstrate the value of multidisciplinary collaboration between radiology and clinical teams; analyze real-world cases highlighting early recognition and risk assessment; discuss evidence-based approaches for optimizing patient outcomes through integrated care pathways.
TARGET AUDIENCE: Diagnostic Radiology, Radiological Technology, Neurologist
AGENDA (7:00–8:30 PM)
• 7:00–7:30 PM — Dr. Faris Hamadi: Neurofibromatosis Plexiform Neurofibroma in the Era of Targeted Therapy
• 7:30–8:00 PM — Dr. Reem Zakzouk: The Radiology of NF1
• 8:00–8:30 PM — Q&A
Moderator: Dr. Ghouth Waggass
SPONSORED BY: AstraZeneca Diagnostics Academy (AZDA) & AstraZeneca
Contact: saudiradiologysociety@gmail.com • X: @rssafeed • www.rssa.sa
